Deep-learning feature-guided design yields antimicrobial peptides D1 and D2
DLFea4AMPGen uses deep-learning activity models and SHAP feature attribution to define peptide fragments used in a candidate sequence space. Sixteen selected peptides were synthesized; the primary article reports 12 with at least two tested activities and identifies D1 and D2 as active against drug-resistant bacterial isolates. D1 also reduced bacterial load in a reported mouse infection experiment. This is preclinical evidence, not human treatment or safety; the study does not establish that every generated sequence or all three activity classes were validated.
Technology: Deep-learning activity prediction and SHAP-guided feature-fragment generation
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: The primary source reports the described assays.
- Still unknown: Independent replication and exhaustive sequence-priority review not established.
- AI role: Deep-learning activity prediction and SHAP-guided feature-fragment generation
Evidence sources: https://www.nature.com/articles/s41467-025-64378-y.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 16 Nov 2026. Review scope: Primary publisher article/indexed full text and bibliographic metadata reviewed for identity, AI role, dates, affiliations, and bounded result..
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.